PD1/PD-L1 targeting in advanced soft-tissue sarcomas: a pooled analysis of phase II trials

by Antoine Italiano, Carine Bellera, Sandra D’Angelo
Published 2020-05-01

368 REVEAL: Phase 1 dose-escalation study of NKTR-262, a novel TLR7/8 agonist, plus bempegaldesleukin: local innate immune activation and systemic adaptive immune expansion for tre...

by Anh Nguyen, Adi Diab, Brendan Curti, Jonathan Zalevsky, Mary Tagliaferri, Christie Fanton, Evidio Domingo-Musibay, Wei Lin, Mehmet Bilen, Sandra D’Angelo, Andrew Brohl, Erkut Borazanci, Cat Haglund, Mona Vimal, Mann Muhsin, Mario Marcondes
Published 2020-11-01